Additionally, compared with the ADVCtrl treatment, treatment with ADVNE or ADVPPE increased the infiltration of M1 macrophages and CD8+ T cells within the tumor microenvironment while reducing the proportion of M2 macrophages. The gene discussed is CD8A; the disease is neoplasm.